Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bajaj Healthcare appoints Shreekumar Shankarnarayan Nair as Chief Operating Officer

Bajaj Healthcare appoints Dr Mohammed Jaweed Mukarram as advisor in RnD division, specializing in APIs

Ruchika Sharma14 Sept 2023 12:30 PM IST

Thane: Bajaj Healthcare Limited, a manufacturer of APIs, Intermediates and Formulations, has announced the appointment of Dr. Mohammed Jaweed...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Bajaj Healthcare gets EIR from USFDA for Vadodara facility

Ruchika Sharma14 Sept 2023 11:30 AM IST

Thane: Bajaj Healthcare Limited (BHL), a manufacturer of APIs, Intermediates and Formulations, has announced the receipt of the Establishment ...

Health Canada approves Moderna COVID vaccine for Omicron, urges boosters

Ruchika Sharma14 Sept 2023 10:15 AM IST

New Delhi: Canadian health officials on Tuesday authorised Moderna's COVID-19 vaccine targeting the Omicron subvariant, urging all Canadians over the...

India AI-powered integrated digital health gateway ekincare raises investment from MSD IDEA Studio Asia Pacific

Foreign investment of up to Rs 9589 crore in Suven Pharma approved by Cabinet

Ruchika Sharma13 Sept 2023 5:19 PM IST

The approved investment aims to generate new jobs, capacity expansion of the Indian company through investments in plant & equipment.

Zydus receives EIR for injectables manufacturing facility at Zydus Biotech Park, Ahmedabad

Ruchika Sharma13 Sept 2023 4:18 PM IST

Ahmedabad: Zydus Lifesciences has announced that the company has received the Establishment Investigation Report (EIR) report from...

USFDA says timeline for supply limits on Novo Nordisk weight loss drug Wegovy unclear

Ruchika Sharma13 Sept 2023 2:30 PM IST

The U.S. Food and Drug Administration has said it was not clear when supply of lower doses of Novo Nordisk's Wegovy would normalize, backtracking from...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck presents new analyses from Sotatercept studies for adults with pulmonary arterial hypertension

Ruchika Sharma13 Sept 2023 1:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced new analyses from studies of sotatercept, Merck’s novel...

Popular decongestant used in cold medicines ineffective: USFDA panel

Ruchika Sharma13 Sept 2023 12:30 PM IST

The panel vote could lead to the removal of oral phenylephrine, which is a major component of popular products like Benadryl, Advil and Tylenol, from...

Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case

Moderna receives USFDA nod for updated COVID vaccine

Ruchika Sharma13 Sept 2023 11:40 AM IST

Cambridge: Moderna, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application(sBLA)...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca seeks to calm CEO speculation after shares drop

Ruchika Sharma12 Sept 2023 4:30 PM IST

London: AstraZeneca appeared to play down speculation about the future of its CEO after its shares fell more than 4% on Monday following a...

Novartis Loses India Patent on Heart Failure Drug Vymada

Novartis discontinues development of GT005 in Geographic Atrophy

Ruchika Sharma12 Sept 2023 3:16 PM IST

Novartis has decided to discontinue development of GT005 (PPY988) in Geographic Atrophy (GA) secondary to dry-Age-related Macular Degeneration...

HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit

Gilead Sciences Trodelvy, Keytruda combo study demonstrates promising clinical activity in first-line Metastatic Non-Small Cell Lung Cancer

Ruchika Sharma12 Sept 2023 2:30 PM IST

Foster City: Gilead Sciences, Inc. has announced promising early data from the global, open-label, Phase 2 EVOKE-02 study evaluating Trodelvy...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok